The markets seem determined to minimize the impact of the omicron variant and bet on the consolidation of economic growth and the benefits of expansionary economic policies. The pandemic continues to introduce elements of uncertainty, poisoning optimism and shattering hopes of international mobility, but investors and large capitals want to end the year better than they did last. The Ibex chained its fourth rise in a day of little activity but disguised as a bullish rally. Grifols and PharmaMar made the greatest progress in a context in which investors must build arguments to take positions for the new year. An annual closing with a clear predominance of purchases and general indices that make up on January 1 with a previous successful closing cannot yet be ruled out. But the specter of new control measures to stem the spread of the coronavirus should not be underestimated. The cancellation of trips and about 4,500 flights on Christmas dates, the record of infections in France, the shadow of new restrictions and even possible confinements cool the spirits. It is time to bet. Due to pandemic or recovery.